• Title/Summary/Keyword: Disease models, animal

Search Result 264, Processing Time 0.026 seconds

Experimental Animal Models for Meniere's Disease: A Mini-Review

  • Seo, Young Joon;Brown, Daniel
    • 대한청각학회지
    • /
    • 제24권2호
    • /
    • pp.53-60
    • /
    • 2020
  • Several novel animal models that represent the pathophysiological process of endolymphatic hydrops (ELH) of Meniere's disease (MD) have been developed. Animal models are important to identify and characterize the pathophysiology of ELH and to corroborate molecular and genetic findings in humans. This review of the current animal models will be useful in understanding the pathophysiology of and developing proper treatments for MD. Surgical animal models will be replaced by medication-induced animal models. Study models previously developed in guinea pigs will be developed in several smaller animals for ease of conducting molecular analysis. In this review, we provided updated resources including our previous studies regarding the current and desirable animal models for MD.

Experimental Animal Models for Meniere's Disease: A Mini-Review

  • Seo, Young Joon;Brown, Daniel
    • Journal of Audiology & Otology
    • /
    • 제24권2호
    • /
    • pp.53-60
    • /
    • 2020
  • Several novel animal models that represent the pathophysiological process of endolymphatic hydrops (ELH) of Meniere's disease (MD) have been developed. Animal models are important to identify and characterize the pathophysiology of ELH and to corroborate molecular and genetic findings in humans. This review of the current animal models will be useful in understanding the pathophysiology of and developing proper treatments for MD. Surgical animal models will be replaced by medication-induced animal models. Study models previously developed in guinea pigs will be developed in several smaller animals for ease of conducting molecular analysis. In this review, we provided updated resources including our previous studies regarding the current and desirable animal models for MD.

Animal Models of Cognitive Deficits for Probiotic Treatment

  • Kwon, Oh Yun;Lee, Seung Ho
    • 한국축산식품학회지
    • /
    • 제42권6호
    • /
    • pp.981-995
    • /
    • 2022
  • Cognitive dysfunction is a common symptom of neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, and Huntington's disease, and is known to be caused by the structural and functional loss of neurons. Many natural agents that can improve cognitive function have been developed and assessed for efficacy using various cognitive deficit animal models. As the gut environment is known to be closely connected to brain function, probiotics are attracting attention as an effective treatment target that can prevent and mitigate cognitive deficits as a result of neurodegenerative diseases. Thus, the objective of this review is to provide useful information about the types and characteristics of cognitive deficit animal models, which can be used to evaluate the anti-cognitive effects of probiotics. In addition, this work reviewed recent studies describing the effects and treatment conditions of probiotics on cognitive deficit animal models. Collectively, this review shows the potential of probiotics as edible natural agents that can mitigate cognitive impairment. It also provides useful information for the design of probiotic treatments for cognitive deficit patients in future clinical studies.

유전자 조작기법을 통한 돼지 뇌종양 질환모델 개발의 필요성 (The Need for the Development of Pig Brain Tumor Disease Model using Genetic Engineering Techniques)

  • 황선웅;현상환
    • 한국수정란이식학회지
    • /
    • 제31권1호
    • /
    • pp.97-107
    • /
    • 2016
  • Although many diseases could be treated by the development of modern medicine, there are some incurable diseases including brain cancer, Alzheimer disease, etc. To study human brain cancer, various animal models were reported. Among these animal models, mouse models are valuable tools for understanding brain cancer characteristics. In spite of many mouse brain cancer models, it has been difficult to find a new target molecule for the treatment of brain cancer. One of the reasons is absence of large animal model which makes conducting preclinical trials. In this article, we review a recent study of molecular characteristics of human brain cancer, their genetic mutation and comparative analysis of the mouse brain cancer model. Finally, we suggest the need for development of large animal models using somatic cell nuclear transfer in translational research.

Evaluation of Therapeutic Efficacy using [18F]FP-CIT in 6-OHDA-induced Parkinson's Animal Model

  • Jang Woo Park;Yi Seul Choi;Dong Hyun Kim;Eun Sang Lee;Chan Woo Park;Hye Kyung Chung;Ran Ji Yoo
    • 대한방사성의약품학회지
    • /
    • 제9권1호
    • /
    • pp.3-8
    • /
    • 2023
  • Parkinson's disease is a neurodegenerative disease caused by damage to brain neurons related to dopamine. Non-clinical animal models mainly used in Parkinson's disease research include drug-induced models of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 6-hydroxydopamine, and genetically modified transgenic animal models. Parkinson's diagnosis can be made using brain imaging of the substantia nigra-striatal dopamine system and using a radiotracer that specifically binds to the dopamine transporter. In this study, 18F-N-(3-fluoropropyl)-2β-carboxymethoxy-3β-(4-iodophenyl) nortropane was used to confirm the image evaluation cutoff between normal and parkinson's disease models, and to confirm model persistence over time. In addition, the efficacy of single or combined administration of clinically used therapeutic drugs in parkinson's animal models was evaluated. Image analysis was performed using the PMOD software. Converted to standardized uptake value, and analyzed by standardized uptake value ratio by dividing the average value of left striatum by the average value of right striatum obtained by applying positron emission tomography images to the atlas magnetic resonance template. The image cutoff of the normal and the parkinson's disease model was calculated as SUVR=0.829, and it was confirmed that it was maintained during the test period. In the three-drug combination administration group, the right and left striatum showed a high symmetry of more than 0.942 on average and recovered significantly. Images using 18F-N-(3-fluoropropyl)-2β-carboxymethoxy-3β-(4-iodophenyl) nortropane are thought to be able to diagnose and evaluate treatment efficacy of non-clinical Parkinson's disease.

Experimental In Vivo Models of Bacterial Shiga Toxin-Associated Hemolytic Uremic Syndrome

  • Jeong, Yu-Jin;Park, Sung-Kyun;Yoon, Sung-Jin;Park, Young-Jun;Lee, Moo-Seung
    • Journal of Microbiology and Biotechnology
    • /
    • 제28권9호
    • /
    • pp.1413-1425
    • /
    • 2018
  • Shiga toxins (Stxs) are the main virulence factors expressed by the pathogenic Stx-producing bacteria, namely, Shigella dysenteriae serotype 1 and certain Escherichia coli strains. These bacteria cause widespread outbreaks of bloody diarrhea (hemorrhagic colitis) that in severe cases can progress to life-threatening systemic complications, including hemolytic uremic syndrome (HUS) characterized by the acute onset of microangiopathic hemolytic anemia and kidney dysfunction. Shiga toxicosis has a distinct pathogenesis and animal models of Stx-associated HUS have allowed us to investigate this. Since these models will also be useful for developing effective countermeasures to Stx-associated HUS, it is important to have clinically relevant animal models of this disease. Multiple studies over the last few decades have shown that mice injected with purified Stxs develop some of the pathophysiological features seen in HUS patients infected with the Stx-producing bacteria. These features are also efficiently recapitulated in a non-human primate model (baboons). In addition, rats, calves, chicks, piglets, and rabbits have been used as models to study symptoms of HUS that are characteristic of each animal. These models have been very useful for testing hypotheses about how Stx induces HUS and its neurological sequelae. In this review, we describe in detail the current knowledge about the most well-studied in vivo models of Stx-induced HUS; namely, those in mice, piglets, non-human primates, and rabbits. The aim of this review is to show how each human clinical outcome-mimicking animal model can serve as an experimental tool to promote our understanding of Stx-induced pathogenesis.

Experimental Animal Models of Coronavirus Infections: Strengths and Limitations

  • Mark Anthony B. Casel;Rare G. Rollon;Young Ki Choi
    • IMMUNE NETWORK
    • /
    • 제21권2호
    • /
    • pp.12.1-12.17
    • /
    • 2021
  • Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Since the emergence of SARS-CoV-2 in the human population in late 2019, it has spread on an unprecedented scale worldwide leading to the first coronavirus pandemic. SARS-CoV-2 infection results in a wide range of clinical manifestations from asymptomatic to fatal cases. Although intensive research has been undertaken to increase understanding of the complex biology of SARS-CoV-2 infection, the detailed mechanisms underpinning the severe pathogenesis and interactions between the virus and the host immune response are not well understood. Thus, the development of appropriate animal models that recapitulate human clinical manifestations and immune responses against SARS-CoV-2 is crucial. Although many animal models are currently available for the study of SARS-CoV-2 infection, each has distinct advantages and disadvantages, and some models show variable results between and within species. Thus, we aim to discuss the different animal models, including mice, hamsters, ferrets, and non-human primates, employed for SARS-CoV-2 infection studies and outline their individual strengths and limitations for use in studies aimed at increasing understanding of coronavirus pathogenesis. Moreover, a significant advantage of these animal models is that they can be tailored, providing unique options specific to the scientific goals of each researcher.

신경과학적 관점으로 본 작업치료에서 동물 모델의 필요성 (What is the Potential of Animal Models to Inform Occupational Therapy Theories and Interventions From the Perspective of Neuroscience?)

  • 박지혁
    • 재활치료과학
    • /
    • 제1권1호
    • /
    • pp.39-56
    • /
    • 2012
  • 서론 : 동물 연구는 작업치료에 직접적으로 적용할 수 없으나, 인간을 대상으로 한 연구와 함께 작업치료의 이론과 임상에 필수적인 지식을 제공한다. 본 논문의 목적은 신경과학적 관점에서 동물모델이 작업치료의 이론과 임상에 어떠한 가능성을 가져다 줄 수 있는지를 살펴보는 것이다. 본론 : 동물 모델을 통해 얻은 지식은 뇌신경 질환의 기전과 관련된 신경 회로에 대한 이해를 돕는다. 이러한 지식을 바탕으로, 연구자들은 뇌신경 질환에 대한 여러 가지 가정들을 동물 모델을 통해 확인해 볼 수 있다. 또한, 여러 동물 실험들을 통해 쌓인 지식들은 인간에게 적용할 수 있는 새로운 치료적 접근들을 제시해 줄 수 있으며 치료에 대한 효율성을 높여줄 수 있다. 결론 : 동물 모델을 통해 얻은 지식은 뇌신경 질환의 기전과 관련된 신경 회로에 대한 이해를 돕는다. 이러한 지식을 바탕으로, 연구자들은 뇌신경 질환에 대한 여러 가지 가정들을 동물 모델을 통해 확인해 볼 수 있다. 또한, 여러 동물 실험들을 통해 쌓인 지식들은 인간에게 적용할 수 있는 새로운 치료적 접근들을 제시해 줄 수 있으며 치료에 대한 효율성을 높여줄 수 있다.

The use of animal models in rheumatoid arthritis research

  • Jin-Sun Kong;Gi Heon Jeong;Seung-Ah Yoo
    • Journal of Yeungnam Medical Science
    • /
    • 제40권1호
    • /
    • pp.23-29
    • /
    • 2023
  • The pathological hallmark of rheumatoid arthritis (RA) is a synovial pannus that comprises proliferating and invasive fibroblast-like synoviocytes, infiltrating inflammatory cells, and an associated neoangiogenic response. Animal models have been established to study these pathological features of human RA. Spontaneous and induced animal models of RA primarily reflect inflammatory aspects of the disease. Among various induced animal models, collagen-induced arthritis (CIA) and collagen antibody-induced arthritis (CAIA) models are widely used to study the pathogenesis of RA. Improved transplantation techniques for severe combined immunodeficiency (SCID) mouse models of RA can be used to evaluate the effectiveness of potential therapeutics in human tissues and cells. This review provides basic information on various animal models of RA, including CIA and CAIA. In addition, we describe a SCID mouse coimplantation model that can measure the long-distance migration of human RA synoviocytes and cartilage destruction induced by these cells.

Therapy of Diabetes Mellitus Using Experimental Animal Models

  • Min, T.S.;Park, Soo Hyun
    • Asian-Australasian Journal of Animal Sciences
    • /
    • 제23권5호
    • /
    • pp.672-679
    • /
    • 2010
  • Diabetes mellitus is a worldwide epidemic with high mortality. As concern over this disease rises, the number and value of research grants awarded by the National Research Foundation of Korea (NRF) have increased. Diabetes mellitus is classified into two groups. Type 1 diabetes requires insulin treatment, whereas type 2 diabetes, which is characterized by insulin resistance, can be treated using a variety of therapeutic approaches. Hyperglycemia is thought to be a primary factor in the onset of diabetes, although hyperlipidemia also plays a role. The major organs active in the regulation of blood glucose are the pancreas, liver, skeletal muscle, adipose tissue, intestine, and kidney. Diabetic complications are generally classified as macrovascular (e.g., stroke and heart disease) or microvascular (i.e., diabetic neuropathy, nephropathy, and retinopathy). Several animal models of diabetes have been used to develop oral therapeutic agents, including sulfonylureas, biguanides, thiazolidinediones, acarbose, and miglitol, for both type 1 and type 2 diseases. This review provides an overview of diabetes mellitus, describes oral therapeutic agents for diabetes and their targets, and discusses new developments in diabetic drug research.